Aspen Pharmacare Holdings Ltd ADR (APNHY PINK) stock market data APIs
$8.6425
-0.12(-1.4%)
as of April 22, 2025
Aspen Pharmacare Holdings Ltd ADR Financial Data Overview
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general, local, and regional anesthetic; low molecular weight heparin; regional and spinal anesthetic; and opioid analegesic under the Diprivan, Emla, Fraxiparine, Marcaine, Ultiva, and Xylocaine brand names. It also offers such as sleeping aid, thyroid hormone, immunosuppressant, iron supplement, analgesic anti-inflammatory, and hormone replacement therapy under the Circadin, Eltroxin, Foxair, Imuran, Maltofer, Mybulen, and Ovestin brand names. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.
Prev. Close
8.6425
Open
8.5259
High
8.6425
Low
8.3109
52 wk Range
7.34-13.5799
Market Cap
3 847 M
P/E Ratio
16.3019
Shares Outstanding
444 M
Revenue
45 525 M
EPS
0.1933
Dividends (Yield)
0.024
Beta
0.578
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Aspen Pharmacare Holdings Ltd ADR data using free add-ons & libraries
Get Aspen Pharmacare Holdings Ltd ADR Fundamental Data
Aspen Pharmacare Holdings Ltd ADR Fundamental data includes:
- Net Revenue: 45 525 M
- EBITDA: 10 792 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2021-06-30
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Aspen Pharmacare Holdings Ltd ADR News
New
Aspen Pharmacare Holdings Ltd (APNHY) (H1 2025) Earnings Call Highlights: Strong Growth Amid ...
Revenue Growth: 9% increase in constant currency, 4% in reported currency. Normalized EBITDA: Up 21% in constant exchange rate (CER), 12% in reported currency. Gross Margin: Growth above 20%. Normaliz...
Investors in Aspen Pharmacare Holdings (JSE:APN) have seen impressive returns of 144% over the past five years
When you buy a stock there is always a possibility that it could drop 100%. But on the bright side, if you buy shares in a high quality company at the right price, you can gain well over 100%. For exa...
Institutional investors are Aspen Pharmacare Holdings Limited's (JSE:APN) biggest bettors and were rewarded after last week's R3.4b market cap gain
Key Insights Significantly high institutional ownership implies Aspen Pharmacare Holdings' stock price is sensitive to their trading actions A total of 7 investors have a majority stake in the compan...
Shareholders May Not Be So Generous With Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation And Here's Why
Key Insights Aspen Pharmacare Holdings' Annual General Meeting to take place on 7th of December Salary of R9.17m is part of CEO Stephen Saad's total remuneration The overall pay is 148% above the ind...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
